Amgen Inc. (AMGN) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - General
About Amgen Inc.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis,…
Source: Yahoo Finance
Sector & Industry
Amgen Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NASDAQ exchange.
Amgen Inc. at a Glance
| Company | Amgen Inc. |
| Ticker | AMGN |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $366.29 |
| Market cap | $197.69B |
| P/E ratio (trailing) | 25.51 |
| EPS (trailing) | $14.36 |
| 52-week high | $391.29 |
| 52-week low | $269.77 |
| Dividend yield | 2.75% |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 31,500 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
What is Amgen Inc.'s P/E ratio?
Amgen Inc. (AMGN) has a trailing P/E ratio of 25.51 as of our latest data snapshot.
What is Amgen Inc.'s market cap?
Amgen Inc.'s market capitalisation is $197.69B based on the most recent snapshot.
What is AMGN's 52-week range?
Over the past 52 weeks, AMGN has traded between $269.77 and $391.29.
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: